About 3 results
Open links in new tab
Phase 2 Trial Supports TYK2 Inhibitor for Cutaneous Lupus
Apr 1, 2025 · After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib in a new trial shows that efficacy extends to …
Skin Rashes in a Patient with Antibodies to Ro/SS-A - Medscape
The skin rashes associated with antibodies to Ro/SS-A in SCLE may wax and wane during the course of the illness. Patients should be instructed to minimize exposure to the sun and …
Systemic Lupus Erythematosus - Medscape
Nov 20, 2025 · Systemic Lupus Erythematosus : Review in-depth clinical information, latest medical news, and guidelines on lupus, systemic lupus erythematosus (SLE). Recognize lupus …